Regencell Bioscience Holdings Limited, a herbal medicine biotech firm, has experienced an astonishing 46,000% surge in its stock value in 2025, despite generating no revenue since its inception. This Hong Kong-based company, specializing in traditional Chinese medicine for neurological conditions, saw its market capitalization soar to $30 billion.
Related Posts
Watch: Hardik Pandya runs across the ground to hug Rahul Dravid
Ahead of their IPL 2025 match, Hardik Pandya and Rahul Dravid, India’s former coach, shared a heartwarming reunion in Jaipur. Dravid, recovering from an injury, […]
Israel hits over 100 Syrian sites linked to Assad regime
Israel launched over 100 airstrikes targeting Syrian military sites, including a suspected chemical weapons research center, weapons depots, and air defense installations. The strikes follow […]